TGA Approval

RYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial (376832)

ARTG ID

376832

ARTG Name

RYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial

Sponsor

Janssen-Cilag Pty Ltd

ARTG Date

December 1, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

JANSSEN-CILAG PTY LTD

https://medical-cdn.nocode.com/drug_tga/6148ba452d923144a312670b54ec2de8.pdf

https://medical-cdn.nocode.com/drug_tga/13f4c296d944cc1d3fd407a9bc155cb3.pdf

Ingredient Name

amivantamab

Empowering clinical research with data-driven insights and AI-powered tools.

RYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial (376832) - TGA 批准文号 | MedPath